Article By:
ChinaBio® Today
Saturday, April 17, 2021 1:00 PM EDT
Sinopharm Group will transfer six of its vaccine companies to Beijing Tiantan Biological Products. Two of the transferring companies have approved COVID-19 vaccines, and Sinopharma said a public listing will facilitate additional sources of funding.